Cargando…
MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13
The aim of this study is to illustrate the biofunctions of miRNA-186-5p level in breast cancer (BCa) and to explore the underlying mechanisms. Levels of miRNA-186-5p in BCa tissues and adjacent normal ones were determined. Association of miRNA-186-5p with pathological parameters and prognosis in BCa...
Autores principales: | Wang, Yulong, Hu, Shaojun, Zhang, Hongbin, Zhang, Chenxin, Lian, Qixin, Jiao, Yu, Zhou, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896921/ https://www.ncbi.nlm.nih.gov/pubmed/35251568 http://dx.doi.org/10.1155/2022/4891889 |
Ejemplares similares
-
Retracted: MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7
por: Apollonova, Vera, et al.
Publicado: (2023) -
Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors
por: Niinuma, Takeshi, et al.
Publicado: (2017) -
The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
por: Xiang, Ying, et al.
Publicado: (2020) -
MicroRNA-186-5p mediates osteoblastic differentiation and cell viability by targeting CXCL13 in non-traumatic osteonecrosis
por: Xu, Weihua, et al.
Publicado: (2019)